Atavistik Bio 和 Pfizer合作开发新的精密癌症治疗方法。 Atavistik Bio and Pfizer collaborate to develop new precision cancer treatments.

Atavistik Bio是一家专门从事精密过敏治疗的生物技术公司,它与辉瑞公司合作,加速发现未满足医疗需要的新疗法。 Atavistik Bio, a biotech firm specializing in precision allosteric therapeutics, has teamed up with Pfizer to accelerate the discovery of new treatments for unmet medical needs. 这些公司将利用Atavistik Bio的AMPSTM平台,为两个未披露的目标确定新的配方粘合剂,以扩大精确肿瘤疗法的潜力。 Using Atavistik Bio's AMPS™ platform, the companies will identify novel allosteric binders for two undisclosed targets, aiming to expand the potential of precision oncology therapies. Pfizer可以选择对研究后产生的方案颁发许可证。 Pfizer has the option to license the resulting programs post-research.